相关实验视频
Updated: Sep 10, 2025

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
TNFR2激动症:多发性硬化和相关疾病的基础科学和有前途的治疗方法
Denise L Faustman1, Miriam Davis2, Willem M Kuhtreiber1
1Laboratory of Immunobiology, Massachusetts General Hospital, and Harvard Medical School, Room 3602, MGH-East, Bldg 149, 13th Street, Boston, MA 02114, USA.
通过向炎症,脱髓化和神经退行,瘤死因受体2 (TNFR2) 的激活对多发性硬化症 (MS) 是有希望的. 这种方法可以为MS患者提供神经保护并对抗不可逆转的残疾.
科学领域:
- 神经免疫学
- 神经生物学
- 脱素的疾病
背景情况:
- 多发性硬化症 (MS) 的特征是炎症,脱髓化和神经退行,目前的治疗方法缺乏全面的作用.
- 在MS中,轴突损失导致不可逆转的残疾,突显了神经保护策略的必要性.
- 现有的多发性硬化疗法无法治疗所有三种核心病理, 也无法提供神经保护.
研究的目的:
- 探索瘤死因受体2 (TNFR2) 作为MS的治疗点.
- 审查TNFR2激素对抗多发性硬化病态和促进神经保护的潜力.
- 讨论TNFR2激素抗体的开发及其应用.
主要方法:
- 在多发性硬化模型中对TNFR2激动性进行基础科学研究的审查.
- 通过TNFR2激活诱导T调节细胞 (Treg) 的分析.
- 检查TNFR2激素抗体设计的最新进展.
主要成果:
- 在多发性硬化模型中,TNFR2激动体表现出免疫抑制,神经保护和分化作用.
- TNFR2激活强烈诱导T调节细胞 (Tregs),特别是TNFR2表达的Tregs,它们具有显著的抑制作用.
- TNFR2的受限表达模式表明它具有良好的安全性,并且系统性副作用是最小的.
结论:
- 针对多面性多发性硬化症,TNFR2激动症是一种独特的治疗策略.
- 针对TNFR2提供了一个神经保护和缓解MS慢性残疾的潜在途径.
- 在TNFR2激素抗体设计的进步可以克服以前的治疗障碍,开辟新的治疗途径.
更多相关视频
12:19Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System
Published on: January 20, 2012
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: